References - - BioPharm International

ADVERTISEMENT

References


BioPharm International


BOOKSAhern TJ, Manning M, eds. Stability of protein pharmaceuticals, part A: chemical and physical pathways of protein degradation. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Ahern TJ, Manning M, eds. Stability of protein pharmaceuticals, part B: in vivo pathways of degradation and strategies for protein stabilization. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Avis KE, Wu VL. Biotechnology and biopharmaceutical manufacturing, processing, and preservation. Drug manufacturing technology series, volume 2. Buffalo Grove (IL):Interpharm Press; 1996.

Banga AK. Electrically assisted transdermal and topical drug delivery. London: Taylor & Francis; 1998.

Bontempo J, ed. Development of biopharmaceutical parenteral dosage forms. New York: Marcel Dekker; 1997.

Carpenter, JF, Chang BS, Garzon-Rodriguez W, Randolph TW. Rational design of stabilized lyophilized protein formulations: theory and practice. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations: theory and practice. New York: Kluwer/Plenum Press; 2002. p. 109-133.

DeSain C. Documentation basics that support good manufacturing practices. Cleveland (OH): Advanstar Communications; 1993.

Hider RC, Barlow D. Polypeptide and protein drugs: production, characterization, and formulation. Ellis Horwood Ltd: Chichester UK; 1991.

Huxsoll JF. Quality assurance for biopharmaceuticals. New York: John Wiley & Sons; 1994.

Kibbe AH, ed. Handbook of pharmaceutical excipients. Third Ed. Washington, DC: American Pharmaceutical Association; 2000.

McNally EJ, ed. Protein formulation and delivery. New York: Marcel Dekker; 2000.

Rowe RC, Roberts RJ. Intelligent software for product formulation. London: Taylor & Francis; 1998.

Saeb-Parsy K, et al., eds. Instant pharmacology. New York: John Wiley & Sons; 1999.

Wang YJ, Pearlman R, eds. Stability and characterization of protein and peptide drugs: case histories. Pharmaceutical biotechnology series, volume 5. New York: Plenum Press; 1993.

Wang YJ, Pearlman R, eds. Formulation, characterization, and stability of protein drugs: case histories. Pharmaceutical biotechnology series, volume 9. New York: Plenum Press; 1996.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here